Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Tables)

v3.20.2
Accrued Expenses And Other Current Liabilities (Tables)
9 Months Ended
Sep. 30, 2020
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of September 30, 2020 and December 31, 2019 consisted of the following: 
  As of
  September 30, 2020 December 31, 2019
Research and development expenses $ 3,381,457  $ 920,901 
Compensation and benefits 2,431,358  1,591,964 
General and administrative 705,867  360,016 
Sales and marketing 142,000  120,056 
Sales returns and allowances 1,520,716  2,284,175 
Medicaid rebates 93,701  118,271 
Lease liability, current 448,659  155,815 
Other 86,964  89,054 
Total accrued expenses and other current liabilities $ 8,810,722  $ 5,640,252